The predecessor of Changchun Changsheng Biotechnology Limited Liability Company was Changchun Changsheng Bio-Technology Company Limited (formerly known as Changchun Changsheng Bio-Tech Co., Ltd.), which is a wholly-owned subsidiary of the listed company Changsheng Bio. Changchun Changsheng Biotechnology Co., Ltd. was established on August 27, 1992, with legal representative Gao Junfang.
From April 2014, in the production of rabies vaccines in the process of serious violations of the relevant provisions of the Code of Practice for the Quality Management of Drug Manufacturing and the National Drug Standard, some of its batches mixed with expired stock, not truthfully fill in the date and batch number, and part of the batch backward labeling of the date of production.
Extended information:
September 2018, ST Changsheng announced that, after the study of high-tech enterprises in Jilin Province, the management body of high-tech enterprise certification, decided to start from the year of 2017 Cancel Changchun Changsheng biotechnology limited liability company high-tech enterprise qualification.?
On October 16, 2018, the State Drug Administration and the Jilin Provincial Food and Drug Administration respectively made a number of administrative penalties on Changchun Changsheng In May 2019, Changsheng Biological Company was investigated.
On April 4, 2019, the State Drug Administration issued a public announcement to cancel 85 drug approval numbers such as ferritin radioimmunoassay kits, of which 19 drug approval numbers were cancelled due to the enterprise being revoked the "Drug Production License" according to the law, 53 due to the enterprise's initiative to apply for the application, and 13 due to the revocation of the drug approval certification documents have been withdrawn.
Baidu Encyclopedia - Changchun Changsheng Biotechnology Co.